The Cooper Parry Corporate Finance team is delighted to have advised Queen’s Park Equity (“QPE”) on the MBO of MediMatch, one of the fastest-growing digitalised dental laboratories in the UK.
MediMatch serves more than 2,000 dentists nationally and also has a presence in Europe with labs in Dublin, Milan and Paris. The business has been growing at ~20% pa over the past three years thanks to its digital-first approach.
MediMatch’s impressive organic growth means it is extremely well positioned to capitalise on a consolidation strategy backed by QPE in the fragmented UK and EU dental laboratory sector. The market is also benefitting from an increase in privately funded dental treatments and the acceleration of the use of intra-oral scanners by dentists globally.
Hugo Van Loenen, MediMatch founder and CEO, said:
“I’m thrilled to be partnering with QPE on this exciting journey. Their sector expertise and buy & build capability will be invaluable as we look to execute our accelerated growth plan over the coming years.”
Sami Igout, Investing at QPE, said:
“We are very excited to be supporting Hugo and the MediMatch team to build on the impressive organic growth they have achieved in recent years. Their success is testament to both the quality and speed at which they serve their customers due to their digital-led approach. We look forward to supporting Hugo on the next phase of growth.”
Niall Chantrill, Partner at Cooper Parry Corporate Finance, added:
“We’re delighted to have advised on another high-profile transaction in one of Cooper Parry’s key sectors – Healthcare. MediMatch is a fantastic business that has grown rapidly in recent years, buoyed by their digital-led approach to serving its customers. Hugo and the MediMatch team have found a great partner in QPE to execute the buy-and-build strategy over the coming years.”
